143 related articles for article (PubMed ID: 33577026)
41. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
42. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
[TBL] [Abstract][Full Text] [Related]
43. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling.
Hu X; Wang R; Ren Z; Liu X; Gu J; Cui G; Li Q
Cancer Med; 2019 Dec; 8(17):7359-7371. PubMed ID: 31637871
[TBL] [Abstract][Full Text] [Related]
44. Effects of CircRNA-ITCH on proliferation and apoptosis of hepatocellular carcinoma cells through inhibiting Wnt/β-catenin signaling pathway.
Yang B; Zhao J; Huo T; Zhang M; Wu X
J BUON; 2020; 25(3):1368-1374. PubMed ID: 32862578
[TBL] [Abstract][Full Text] [Related]
45. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.
Ma X; Ma X; Qiu Y; Zhu L; Lin Y; You Y; Ma D; Qin Z; Sun C; Zhao Y; Sun Y; Han L
Cell Death Dis; 2018 May; 9(6):608. PubMed ID: 29789583
[TBL] [Abstract][Full Text] [Related]
46. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
47. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
[TBL] [Abstract][Full Text] [Related]
48. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
49. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
51. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
52. Circ_0000515 drives the progression of hepatocellular carcinoma by regulating MAPK10.
Li H; Li CM; Yuan R; Wang HB; Wei J
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6014-6022. PubMed ID: 32572915
[TBL] [Abstract][Full Text] [Related]
53. MiR-224 Executes a Tumor Accelerative Role during Hepatocellular Carcinoma Malignancy by Targeting Cytoplasmic Polyadenylation Element-Binding Protein 3.
Miao K; Liu SD; Huang WX; Dong H
Pharmacology; 2020; 105(7-8):477-487. PubMed ID: 32454494
[TBL] [Abstract][Full Text] [Related]
54. MiRNA-15a-3p inhibits the metastasis of hepatocellular carcinoma by interacting with HMOX1.
Jiang C; He ZL; Hu XH; Ma PY
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12694-12700. PubMed ID: 33378016
[TBL] [Abstract][Full Text] [Related]
55. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
56. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
Ren F; Su H; Jiang H; Chen Y
J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
[TBL] [Abstract][Full Text] [Related]
58. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
59. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway.
Liao S; Chen H; Liu M; Gan L; Li C; Zhang W; Lv L; Mei Z
Aging (Albany NY); 2020 Jan; 12(2):1527-1544. PubMed ID: 31969493
[TBL] [Abstract][Full Text] [Related]
60. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
Huang C; Li K; Huang R; Zhu J; Yang J
Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
